Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
15 participants
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SpO2 Hypoxia Accuracy Validation Study
NCT03348189
Induced Hypoxia Study for Validation of SpO2 Accuracy
NCT00788983
SpO2 Accuracy Low Saturation Validation of the OxySoftN Sensor
NCT04811963
Hypoxia Blood Validation in Multiple Pulse Oximeters
NCT00881829
SpO2 Accuracy Validation of the OxySoft Sensor Via Reference CO-Oximetry Motion Study
NCT04559763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SpO2 and pulse rate measurements reported by ViSi will be compared with simultaneous measurements of blood SaO2 and pulse rate made by an FDA-cleared CO-oximeter and pulse oximeter, respectively. The paired measurements will be made in a well-controlled environment under optimal laboratory conditions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is a healthy volunteer capable of undergoing controlled hypoxemia to the level of 70% SaO2 (±3%) with no or minimal medical risk.
* Subject is willing and able to participate in the measurement period for up to two hours.
Exclusion Criteria
* Subject has a MetHb level ≥2%.
* Subject has a ctHb value ≤10g/dl.
* Subject is in another clinical study that may interfere with the results of this study.
* Subject is unable or unwilling to have a blood gas and oxygen saturation measurements taken from either wrist/hand.
* Subject is deemed by the Investigator to be medically unsuitable for participation in this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sotera Wireless, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sotera Wireless, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip S. Clifford, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinimark Desaturation Laboratory
Louisville, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SWI-US11-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.